Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).

Conditions:   Diabetes;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2 Intervention:   Device: Continuous Glucose Monitor Sponsors:   University of Virginia;   DexCom, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials